SKBioland Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
9,728
10,563
10,785
12,426
11,979
Depreciation, Depletion & Amortization
6,472
5,552
3,845
4,295
5,765
Other Funds
1,266
2,421
2,029
3,229
1,805
Funds from Operations
14,656
17,923
12,580
13,711
15,825
Changes in Working Capital
1,485
5,592
1,555
391
1,953
Net Operating Cash Flow
16,141
12,331
11,024
13,320
13,872
Capital Expenditures
4,704
5,818
7,478
14,648
16,743
Sale of Fixed Assets & Businesses
23
96
1,369
73
2
Purchase/Sale of Investments
4,795
4,242
11,682
4,906
9,168
Net Investing Cash Flow
376
1,487
16,961
9,915
8,074
Cash Dividends Paid - Total
3,000
3,000
3,750
3,750
3,750
Issuance/Reduction of Debt, Net
8,850
8,150
1,158
4,300
2,286
Net Financing Cash Flow
11,850
11,150
2,592
550
1,464
Net Change in Cash
4,571
256
8,341
4,048
4,156
Free Cash Flow
11,931
6,888
3,552
1,000
2,386
Deferred Taxes & Investment Tax Credit
278
614
22
218
114
Other Sources
823
136
829
567
495
Exchange Rate Effect
97
50
188
93
178
Other Uses
561
142
-
813
996

About SKBioland Co.

View Profile
Address
59 Songjeongni 2-gil
Cheonan SC 31257
Korea, Republic Of
Employees -
Website http://www.skbioland.com
Updated 09/14/2018
SKbioland Co. Ltd. engages in the manufacture and sale of pharmaceutical and functional products. It operates through the following business divisions: Cosmetics Ingredients, Functional Food Ingredients, Active Pharmaceuticals Ingredients, and Biomedical Devices. The Cosmetics Ingredients divison supplies non-toxic and non-stimulus ingredients.